Actively Recruiting
Precision Optical Guidance for Oral Biopsy
Led by M.D. Anderson Cancer Center · Updated on 2026-04-16
90
Participants Needed
1
Research Sites
197 weeks
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
N
National Institute of Dental and Craniofacial Research (NIDCR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
To learn if a new type of imaging device called the Active Biopsy Guidance System can help doctors to decide when and where to perform invasive biopsies of mouth lesions.
CONDITIONS
Official Title
Precision Optical Guidance for Oral Biopsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult subjects with visible oral lesions such as leukoplakia or erythroplakia, oral potentially malignant disorders like lichen planus or graft vs. host disease, diagnosed dysplasia, squamous cell carcinoma, or history of oral cancer surgery are eligible
- Patients with prior treatments including surgery, radiation, chemotherapy, or other therapies can participate
- Ability to understand and sign a written informed consent document
You will not qualify if you...
- Known allergy to proflavine or acriflavine
- Age less than 18 years
- Pregnant or nursing females
- Adults unable to give consent
- Prisoners and other vulnerable populations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
A
Ann Gillenwater, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here